Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 µM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 µM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain[1][2][3].
Molekulargewicht:
430.97
Reinheit:
99.62
CAS Nummer:
[1440796-75-7]
Formel:
C21H35ClN2O5
Target-Kategorie:
5-HT Receptor,GlyT,P2X Receptor
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten